missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CKAP2L (aa 608-713) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (64%), Rat (64%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-84849 (PA5-84849. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene is thought to be a mitotic spindle protein important to neural stem or progenitor cells. Mutations in this gene have been associated with spindle organization defects, including mitotic spindle defects, lagging chromosomes, and chromatin bridges. There is evidence that mutations in this gene are associated with Filippi syndrome, characterized by growth defects, microcephaly, intellectual disability, facial feature defects, and syndactyly. There is a pseudogene of this gene on chromosome 20. Alternative splicing results in multiple transcript variants.
Especificaciones
Especificaciones
| Accession Number | Q8IYA6 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 150468 |
| Name | Human CKAP2L (aa 608-713) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | CKAP2L; cytoskeleton associated protein 2 like; cytoskeleton associated protein 2-like; cytoskeleton-associated protein 2-like; FLJ40629; Radial fiber and mitotic spindle protein; radmis |
| Common Name | CKAP2L |
| Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido